fda approval of tirzepatide for weight loss approves (Zepbound) injection chronic management, with 72-week trials showing statistically significant body-weight reduction in adults with obesity or overweight GROUNDBREAKING UPDATE! FDA has approved

These medications dont cause these changes directly

Preserving skeletal muscle is essential for lasting results, as muscle loss significantly increases the risk of rebound weight gain

This reduction in calorie intake ultimately leads to weight loss over time

They aim for broader metabolic effects (lipids, weight loss, energy expenditure etc.)

Liproxstatin-1 maintains the integrity of the blood-spinal barrier by upregulating the expression of tight junction proteins and reduces ferroptosis in endothelial cells by upregulating GPX4 and downregulating ACSL4 and ALOX5

When used together, these peptides address aging from multiple anglesboth cosmetic and cellular